Details

Dual inhibitors of p38α mitogen-activated protein kinase and butyrylcholinesterase for the modulation of neuroinflammation and cognitive dysfunction
ID Knez, Damijan (Author), ID Meden, Anže (Author), ID Ferjančič Benetik, Svit (Author), ID Pišlar, Anja (Author), ID Musílek, Kamil (Author), ID Gobec, Stanislav (Author), et al.

.pdfPDF - Presentation file, Download (7,24 MB)
MD5: 5EEE376E13134C1AE0F8B5E0B9DD7AB6
URLURL - Source URL, Visit https://pubs.acs.org/jmcmar/article/69/16/19891/5251523/Dual-Inhibitors-of-p38-Mitogen-Activated-Protein This link opens in a new window

Abstract
Chronic neuroinflammation and cholinergic dysfunction are major contributors to cognitive decline in Alzheimer’s disease. Here, we report a series of pyridazine-based multitarget-directed ligands that simultaneously inhibit human butyrylcholinesterase (hBChE) and p38α mitogen-activated protein kinase (p38α MAPK). Pyridazines 8 and 21 were identified as potent dual inhibitors with submicromolar inhibitory potencies against target enzymes and high selectivity over acetylcholinesterase. X-ray crystallographic analyses revealed the experimental binding modes of 8 and 21 in hBChE and p38α MAPK, and identified conserved π–π, π–cation, and hinge region interactions that rationalize dual-target engagement. Both compounds were blood-brain barrier permeable, exhibited low cytotoxicity, and significantly attenuated lipopolysaccharide-induced proinflammatory responses and apoptosis in BV2 microglia. In vivo, compound 21 enhanced cognitive performance in mouse models of scopolamine-induced amnesia and LPS-stimulated neuroinflammatory cognitive impairment. Collectively, these results document the potential of structure-assisted design to achieve selective dual-target pharmacology within a single molecular entity.

Language:English
Keywords:inflammation, inhibitors, peptides and proteins, nervous system diseases, rodent models
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:Str. 19891-19917
Numbering:Vol. 69, iss. 16
PID:20.500.12556/RUL-189714 This link opens in a new window
UDC:615.2-021.321:616.894
ISSN on article:1520-4804
DOI:10.1021/acs.jmedchem.6c01461 This link opens in a new window
COBISS.SI-ID:289183747 This link opens in a new window
Publication date in RUL:13.10.2026
Views:75
Downloads:35
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of medicinal chemistry
Shortened title:J. med. chem.
Publisher:American Chemical Society
ISSN:1520-4804
COBISS.SI-ID:512806681 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:zaviralci vnetja, peptidi in beljakovine, bolezni živčnega sistema, modeli glodalcev, Alzheimerjeva bolezen, tarčna zdravila

Projects

Funder:NCN - National Science Centre
Project number:DEC-2021/43/I/NZ7/00342

Funder:GAČR - Czech Science Foundation
Project number:GF23-42701L

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:N1-0277
Name:Raziskave multifunkcionalnih spojin, usmerjenih proti nevroinflamaciji in holinergičnemu pomanjkanju pri Alzheimerjevi bolezni

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young researchers

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:BI-FR/23-24-PROTEUS-002
Name:Razvoj učinkovitih reaktivatorjev z organofosfati zavrte butirilholin esteraze

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:University of Ljubljana, Great Interdisciplinary Project

Funder:University of Hradec Kralove, Faculty of Science
Funding programme:Excellence project
Project number:2206/2025-2026

Funder:MH CZ - Czech Republic
Funding programme:DRO
Project number:00179906
Acronym:UHHK

Funder:French Ministry of Armed Forces
Project number:NBC-5-C-2316

Funder:Jagiellonian University, Medical College
Funding programme:Statutory funds
Project number:N42/DBS/000454

Funder:MIZŠ - Ministry of Education, Science, and Sport
Project number:OP20.05187
Acronym:RI-SI-EATRIS

Funder:EC - European Commission
Funding programme:European Regional Development Fund
Acronym:RI-SI-EATRIS

Funder:NIH - National Institutes of Health
Project number:AG062095

Funder:NIH - National Institutes of Health
Project number:AG043415

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back